<DOC>
	<DOCNO>NCT00274755</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , magnetic resonance imaging ( MRI ) magnetic resonance spectroscopic imaging ( MRSI ) , ( do , , treatment ) may help doctor predict patient 's response treatment help plan best treatment . PURPOSE : This phase II trial study well MRI MRSI evaluate patient undergoing treatment glioma .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Magnetic Resonance Spectroscopic Imaging Evaluating Patients Who Are Undergoing Treatment Gliomas</brief_title>
	<detailed_description>OBJECTIVES : - Determine magnetic resonance spectroscopic imaging ( MRSI ) characteristic patient undergo treatment supratentorial glioma . - Determine survival patient undergo magnetic resonance imaging MRSI . - Determine clinical outcome patient undergo imaging procedure . - Correlate measure metabolic tumor burden ( i.e. , CNI , CCCrI , CrNI , LLI ) survival clinical outcome patient undergo imaging procedure . - Determine time clinical progression patient undergo imaging procedure . OUTLINE : Patients assign 1 2 treatment group base grade disease . - Group 1 ( patient grade II glioma ) : Patients undergo magnetic resonance imaging ( MRI ) magnetic resonance spectroscopic imaging ( MRSI ) . Patients receive chemotherapy . Patients undergo repeat MRI/MRSI course 2 4 chemotherapy . - Group 2 ( patient grade III-IV glioma ) : Patients undergo MRI/MRSI undergo surgical resection tumor . Patients receive chemoradiotherapy . Patients undergo repeat MRI/MRSI within 2 week 2 month completion radiotherapy . Patients follow recurrence , disease progression , survival . PROJECTED ACCRUAL : A total 250 patient accrue study .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm supratentorial glioma Grade IIIV disease Previously untreated disease Eligible surgical resection and/or chemotherapy without radiotherapy Tumor accessible magnetic resonance spectroscopic image PATIENT CHARACTERISTICS : Karnofsky performance status 60100 % Life expectancy â‰¥ 8 week Not pregnant No contraindication magnetic resonance examination , include follow : Cardiac pacemaker fibrillator Aneurysm clip Insulin infusion pump Any implant hold place magnet Metal contamination anywhere body PRIOR CONCURRENT THERAPY : No prior chemotherapy No prior radiotherapy No prior treatment malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult ependymoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult mixed glioma</keyword>
</DOC>